ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Neuronetics (STIM)
Neuronetics stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$2.23▼ -0.45%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Neuronetics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Neuronetics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Neuronetics a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.94 and $2.48; in 9 out of 10, between $1.56 and $3.09. Estimated annual volatility is 66%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $165M
- 52-week high
- $3.44
- 52-week low
- $1.18
- Revenue (12 months)
- $155M
- Revenue growth (YoY)
- +99.2%
- Gross margin
- 48.5%
- Operating margin
- -21.1%
- Net margin
- -26.2%
- Return on equity
- -116.1%
- Free cash flow (12 months)
- $0.3M
- Beta
- 1.17
What this means
ATLAS does not publish a fair value for STIM right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks STIM has traded between $1.18 and $3.44. Today it is 35.2% below that high and 89% above its low.
On the business: revenue grew 99.2% year over year; net margin is 26.2%.
Its beta is 1.17: it tends to move more than the market, both up and down.
About the company
Neuronetics Inc. is a commercial-stage medical technology company focused on non-invasive neurohealth treatments. Its core offering is the NeuroStar Advanced Therapy System, an office-based transcranial magnetic stimulation platform used primarily for adult patients with major depressive disorder.
Want to see everything about Neuronetics?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Neuronetics do?
Neuronetics Inc. is a commercial-stage medical technology company focused on non-invasive neurohealth treatments. Its core offering is the NeuroStar Advanced Therapy System, an office-based transcranial magnetic stimulation platform used primarily for adult patients with major depressive disorder.
What is the chance STIM goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, STIM ends the month between $1.94 and $2.48.
How big is Neuronetics and what is its P/E ratio?
Neuronetics's market capitalization is $165M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is STIM?
ATLAS estimates annual volatility at 66%. In a typical month, half of the outcomes end between $1.94 and $2.48.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer